Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Passage BIO, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +1 vs. Q2 2021
- Shares held
- 42.1M
- −2.51M (−5.6%) vs. Q2 2021
- Total value
- $419.1M
- −$139.7M (−25.0%) vs. Q2 2021
- New holders
- 17
- 31 more added
- Sold out
- 16
- 32 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Investors Research Corp | 50 | $0 | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 7 | $0 | 0.00% | −13−65.0% | Reduced |
| Ellevest, Inc. | 8 | $0 | 0.00% | +8 | New |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −290,213−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −187,500−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −84,800−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −70,687−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −67,050−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −37,689−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −31,247−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −25,650−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −24,400−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −15,384−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,417−100.0% | Sold out |
| HC Advisors, LLC | 0 | $0 | 0.00% | −10,912−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −3,600−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |